A short history of peptide drugs: 1922 to today
Published October 26, 2026. Based on a 2025 review paper, cited below.
Quick take: peptides are not a new fad. The first major peptide therapy is over a century old, and nearly 100 peptide drugs are now approved worldwide.
The timeline
| Year | Milestone |
|---|---|
| 1922 | Insulin, extracted from animals, is used to treat type 1 diabetes. The first major peptide therapy. |
| 1950s | Oxytocin and vasopressin are synthesized, and solid phase peptide synthesis arrives, making larger scale production possible. |
| 1989 | Goserelin is approved for cancer. |
| 2003 | Enfuvirtide is approved for HIV. |
| 2019 | Oral semaglutide is approved for type 2 diabetes. |
| Nov 2023 | Tirzepatide arrives for weight management and blood sugar control. |
The numbers behind the boom
- Nearly 100 peptide drugs are approved worldwide, and more than 60 were approved in the past two decades.
- 38 peptide drugs were in phase III trials, per the review.
- The review projects the market at $68.83 billion by 2028, up from $41.44 billion in 2023.
- Metabolic drugs held 37.8% of the market in 2023.
Where the field is heading
Injection is still the most common route, and oral versions are a major research goal. Cancer overtook type 2 diabetes as the most frequent research keyword in 2020 to 2024.
See also: the two drug race and what research use only means.
Ready to order?
Paste it in the Promo code box in the order summary at checkout, then press Apply. Confirm the discount line before you pay.
Common questions
What was the first peptide drug?
Insulin, first used to treat type 1 diabetes in 1922.
How many peptide drugs are approved?
Nearly 100 worldwide, per a 2025 review.
Are peptides new?
No. Peptide therapy is over a century old.
Sources
Summarised in my own words. Read the originals for the full detail.